Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Aryeh Jason sold 282 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Nov 4, 2026 · Filed Nov 6, 2026
On Nov 4, 2026, Aryeh Jason (Director) sold 282 Ligand Pharmaceuticals Incorporated shares at US$319.99 for US$90,237, leaving 108,476 shares. Filed Nov 6, 2026 (Form 4).
- Sold
- 282 shares
- Price
- US$319.99
- Value
- US$90,237
- Holding after
- 108,476 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Common Stock | Sale | 282 | US$319.99 | 108,476 | Direct |
Source
Download original · View original at SEC
Related
- Ligand Pharmaceuticals Incorporated
- Aryeh Jason
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Aryeh Jason · Nov 12, 2026
- Form 4 · Aryeh Jason · Nov 3, 2026
- Form 4 · Aryeh Jason · Jun 12, 2026
- Form 4 · Kozarich John W · Nov 16, 2026
- Form 4 · Zimmermann Martine · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Schedule 13G/A · Invesco Ltd. · Nov 10, 2026
- Form 4 · Reardon Andrew · Nov 4, 2026